XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Operating activities:    
Net loss for the period $ (2,050,551) $ (3,533,284)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 336,366 410,555
Stock issued for services 762,794 114,491
Depletion 233,798 239,002
Depreciation 31,768 37,633
Accretion of asset retirement obligation 416,354 377,197
Accretion expense 146,329 34,586
Change in fair value of derivative liability (1,473,638) 199,789
Unrealized foreign exchange loss 53,699 1,813
Accrued interest 49,409 80,278
Interest income (17,733)
Loss on debt settlement 238,724 22,406
Provision for loan receivable 54,008
Gain on disposal of equipment (40,074)
Changes in operating assets and liabilities:    
Accounts receivable (469,752) (234,969)
Prepaid expenses and deposits (71,201) 5,733
Accounts payable and accrued liabilities (18,680) 565,459
Lease payments (11,114) (25,369)
Net cash used in operating activities (1,883,502) (1,650,672)
Investing activities:    
Property and equipment expenditures (180,739) (73,725)
Disposal of equipment 65,016
Oil and gas properties expenditures (66,122) (5,084)
Net cash used in investing activities (181,845) (78,809)
Financing activities:    
Proceeds from stock subscriptions received 544,880 1,004,228
Proceeds from loans payable 525,642 83,651
Proceeds from exercise of options 191,032
Proceeds from exercise of warrants 1,772,884
Repayment of loans payable (394,883) (59,177)
Repayment of notes receivable 23,745
Proceeds from convertible debt
Net cash provided by financing activities 2,663,300 1,028,702
Effect of exchange rate changes on cash and cash equivalents 220,000 (44,669)
Net increase (decrease) in cash, cash equivalents, and restricted cash 817,953 (745,448)
Cash, cash equivalents and restricted cash, beginning of year 214,475 959,923
Cash, cash equivalents and restricted cash, end of year 1,032,428 214,475
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents, end of period 1,026,990 202,712
Restricted cash, end of period 5,438 11,763
Cash, cash equivalents and restricted cash, end of period 1,032,428 214,475
Supplemental Cash Flow Information:    
Accounts payable and debt settled by issuance of shares 198,782 355,087
Warrants exercised to settle debt 194,359
Warrants issued to settle debt 152,750
Initial recognition of right-of-use asset 57,919
Stock issued for conversion of debentures 601,860
Cash interest paid $ 29,980 $ 14,515